{"nct_id":"NCT02574637","title":"Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease","status":"TERMINATED","status_verified_date":"2021-05","start_date":"2016-01-05","start_date_type":"ACTUAL","primary_completion_date":"2017-07-28","primary_completion_date_type":"ACTUAL","completion_date":"2018-01-29","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}